Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Dec 31;9(4):110-2.
doi: 10.3315/jdcr.2015.1214.

Ichthyosis linearis circumflexa in a child. Response to narrowband UVB therapy

Ralfi Singer  1 , Mehmet Çopur  1 , Ece Nur Yüksel  1 , Emek Kocatürk  1 , Selma Şengiz Erhan  2
Affiliations
Case Reports

Ichthyosis linearis circumflexa in a child. Response to narrowband UVB therapy

Ralfi Singer et al. J Dermatol Case Rep. .

Abstract

Background: Ichthyosis linearis circumflexa is a rare form of ichthyosis characterized by polycyclic and annular lesions which are bordered by a double-edged scale. Netherton syndrome is a genodermatosis in which ichthyosis linearis circumflexa is accompanied by characteristic hair shaft abnormalities and atopic diathesis. Different treatment modalities such as emmolients, keratolytics, calcipotriene, topical corticosteroids, topical calcineurin inhibitors, systemic retinoids, phototherapy and photochemotherapy have been used with variable results. Topical therapies may result in considerable absorption because of the defective barrier function in ichthyosis linearis circumflexa/Netherton syndrome.

Main observation: A 12-year-old patient diagnosed as ichthyosis linearis circumflexa demonstrated considerable improvement with narrowband UVB phototherapy at the end of 30 sessions.

Conclusion: Short-term narrowband-UVB may an effective treatment option in patients with ichthyosis linearis circumflexa/Netherton syndrome.

Keywords: Netherton syndrome; UV; ichthyosis; phototherapy; treatment; trichorrhexis invaginata.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A,B) Widespread, erythematous, polycyclic, scaly eruption with double-edged scales.
Figure 2
Figure 2
(A,B) Clinical improvement of skin lesions after phototherapy.
See this image and copyright information in PMC

References

    1. Richard G, Ringpfeil F. Ichthyoses, Erythrokeratodermas and Related Disorders. In: Dermatology (Jorizzo JL, Bolognia JL, Schaffer JV, eds), 3rd edn, Vol.1. Elsevier Saunders Company; 2012. pp. 837–870.
    1. Maatouk I, Moutran R, Tomb R. Narrowband ultraviolet B phototherapy associated with improvement in Netherton syndrome. Clin Exp Dermatol. 2012;37:364–366. - PubMed
    1. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A. Mutations in SPINK5, encoding a serine protease inhibitor cause Netherton syndrome. Nat Genet. 2000;25:141–142. - PubMed
    1. Kaminska EC, Ortel B, Sharma V, Stein SL. Narrowband UVB phototherapy as a novel treatment for Netherton syndrome. Photodermatol Photoimmunol Photomed. 2012;28:162–164. - PubMed
    1. Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, Korman NJ. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol. 2001;137:747–750. - PubMed

Publication types

LinkOut - more resources